Literature DB >> 25025814

Hydrogen peroxide inactivation of influenza virus preserves antigenic structure and immunogenicity.

Jennifer L Dembinski1, Olav Hungnes2, Anna Germundsson Hauge3, Anne-Cathrine Kristoffersen4, Bjørn Haneberg4, Siri Mjaaland5.   

Abstract

The use of live virus in the laboratory requires additional precautions, such as personnel training and special equipment, in order to limit the transmission risk. This is a requirement which not all laboratories can fulfill. In this study, a viral inactivation method is introduced using hydrogen peroxide (H2O2), which maintains antigenicity. Three strains of influenza viruses were inactivated and the ex vivo cellular and humoral immune responses were further analyzed, by comparing them to live viruses, in ELISpot, Multiplex and ELISA assays. In all assays, the H2O2 inactivated viruses displayed comparable responses to the live viruses, suggesting that the inactivated viruses still elicited immunogenic responses even though inactivation was confirmed by lack of viral replication in MDCK cells. Taken together, this study demonstrates that influenza viruses inactivated with H2O2 retain immunogenicity and are able to both detect humoral and elicit cellular immune responses in vitro, which could reduce the need to handle live viruses in the laboratory.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydrogen peroxide; Immune response; Immunogenic; Inactivation; Influenza virus

Mesh:

Substances:

Year:  2014        PMID: 25025814     DOI: 10.1016/j.jviromet.2014.07.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  19 in total

1.  Vaccines. An Ebola whole-virus vaccine is protective in nonhuman primates.

Authors:  Andrea Marzi; Peter Halfmann; Lindsay Hill-Batorski; Friederike Feldmann; W Lesley Shupert; Gabriele Neumann; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Science       Date:  2015-03-26       Impact factor: 47.728

2.  Biomimetic recyclable microgels for on-demand generation of hydrogen peroxide and antipathogenic application.

Authors:  Hao Meng; Pegah Kord Forooshani; Pratik U Joshi; Julie Osborne; Xue Mi; Christa Meingast; Rattapol Pinnaratip; Jonathan Kelley; Ameya Narkar; Weilue He; Megan C Frost; Caryn L Heldt; Bruce P Lee
Journal:  Acta Biomater       Date:  2018-10-26       Impact factor: 8.947

Review 3.  Recent advances in antiviral effects of probiotics: potential mechanism study in prevention and treatment of SARS-CoV-2.

Authors:  Nima Montazeri-Najafabady; Kimia Kazemi; Ahmad Gholami
Journal:  Biologia (Bratisl)       Date:  2022-06-28       Impact factor: 1.653

Review 4.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

5.  High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia.

Authors:  Jennifer L Dembinski; Adane Mihret; Solomon A Yimer; Bamlak Tessema; Mai-Chi Trieu; Azeb Tarekegn; Nahom Getachew; Rebecca J Cox; Fredrik Oftung; Bjørn Haneberg; Abraham Aseffa; Siri Mjaaland
Journal:  Open Forum Infect Dis       Date:  2017-02-11       Impact factor: 3.835

6.  Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study.

Authors:  Pål Voltersvik; Lara A Aqrawi; Susanne Dudman; Olav Hungnes; Leif Bostad; Karl A Brokstad; Rebecca J Cox
Journal:  Influenza Other Respir Viruses       Date:  2016-09-01       Impact factor: 4.380

7.  Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.

Authors:  Miloje Savic; Jennifer L Dembinski; Ida Laake; Olav Hungnes; Rebecca Cox; Fredrik Oftung; Lill Trogstad; Siri Mjaaland
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

Review 8.  Ebola and Marburg virus vaccines.

Authors:  Pierce Reynolds; Andrea Marzi
Journal:  Virus Genes       Date:  2017-04-26       Impact factor: 2.332

Review 9.  Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.

Authors:  Paul Löffler
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Authors:  Kristin G-I Mohn; Rebecca Jane Cox; Gro Tunheim; Jan Erik Berdal; Anna Germundsson Hauge; Åsne Jul-Larsen; Bjoern Peters; Fredrik Oftung; Christine Monceyron Jonassen; Siri Mjaaland
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.